The Therapy remains fairly new in terms of widespread acceptance, and It can be frequently categorised being an "off-label" use for depression, that means its use During this context has not been formally permitted because of the FDA. This classification causes it to be tricky for Medicare to justify coverage. https://g.co/kgs/7Pv1MXH